BlackRock, Inc. 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-28 07:56 am Sale | 2025-03-31 | 13G | Collegium Pharmaceutical, Inc. COLL | BlackRock Inc. BLK | 4,997,827 15.600% | -788,700 (-13.63%) | Filing |
| 2024-01-19 2:40 pm Purchase | 2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | BlackRock Inc. BLK | 5,786,527 17.700% | 55,222 (+0.96%) | Filing |
| 2023-01-30 09:55 am Purchase | 2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | BlackRock Inc. BLK | 5,731,305 17.100% | 99,645 (+1.77%) | Filing |
| 2022-01-28 2:07 pm Sale | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | BlackRock Inc. BLK | 5,631,660 16.300% | -244,012 (-4.15%) | Filing |
| 2021-03-09 6:33 pm Purchase | 2021-02-28 | 13G | Collegium Pharmaceutical, Inc. COLL | BlackRock Inc. BLK | 5,875,672 16.900% | 3,037,455 (+107.02%) | Filing |